Karim A Diab (Karim Diab)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Stem Cell Transplantation

Replacement Therapy

Left Ventricular

Top Venues

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Deepa H Chand, Rui Sun, Karim A Diab, Damien Kenny, Francis Fonyuy Tukov
Review of cardiac safety in onasemnogene abeparvovec gene replacement therapy: translation from preclinical to clinical findings. Gene therapy (2023)
Deepa H Chand, Rui Sun, Karim A Diab, Damien Kenny, Francis Fonyuy Tukov
Review of cardiac safety in onasemnogene abeparvovec gene replacement therapy: translation from preclinical to clinical findings. Gene therapy (2023)
Deepa H Chand, Rui Sun, Karim A Diab, Damien Kenny, Francis Fonyuy Tukov
Review of cardiac safety in onasemnogene abeparvovec gene replacement therapy: translation from preclinical to clinical findings. Gene therapy (2023)
Deepa H Chand, Rui Sun, Karim A Diab, Damien Kenny, Francis Fonyuy Tukov
Review of cardiac safety in onasemnogene abeparvovec gene replacement therapy: translation from preclinical to clinical findings. Gene therapy (2023)
Deepa H Chand, Rui Sun, Karim A Diab, Damien Kenny, Francis Fonyuy Tukov
Review of cardiac safety in onasemnogene abeparvovec gene replacement therapy: translation from preclinical to clinical findings. Gene therapy (2023)
Wadi Mawad, Lisa K Hornberger, Bettina F Cuneo, Marie-Josée Raboisson, Anita J Moon-Grady, Jane Lougheed, Karim A Diab, Julia Parkman, Earl Silverman, Edgar Jaeggi
Outcome of Antibody-Mediated Fetal Heart Disease With Standardized Anti-Inflammatory Transplacental Treatment. Journal of the American Heart Association 11 (3) (2022)
Edgar T Jaeggi, Lisa K Hornberger, Bettina F Cuneo, Anita J Moon-Grady, Marie-Josée Raboisson, Jane Lougheed, Karim A Diab, Wadi Mawad, Earl D Silverman
To Be or Not to Be: Surviving Immune-Mediated Fetal Heart Disease. Journal of the American Heart Association 11 (13) (2022)